United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
499.73
-1.54 (-0.31%)
Aug 14, 2026, 4:00 PM EDT - Market closed
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Tyvaso
1.85B1.87B1.88B1.83B1.79B1.71B1.62B1.56B
Tyvaso Growth
3.74%9.05%15.91%17.66%23.39%25.33%31.34%38.18%
Orenitram
513.60M511.80M496.90M483.50M465.60M448.80M434.30M410.60M
Orenitram Growth
10.31%14.04%14.41%17.75%19.57%18.92%20.84%16.95%
Remodulin
506.80M515.20M526.80M533.30M535.70M548.30M538.10M518.70M
Remodulin Growth
-5.39%-6.04%-2.10%2.81%2.72%9.35%8.75%3.29%
Unituxin
229.00M222.20M226.80M232.00M245.20M238.50M238.70M225.40M
Unituxin Growth
-6.61%-6.83%-4.99%2.93%13.73%14.55%20.01%24.26%
Adcirca
27.10M26.90M30.00M26.90M24.20M23.40M23.80M25.90M
Adcirca Growth
11.98%14.96%26.05%3.86%-7.63%-16.43%-17.65%-20.31%
Other
25.60M24.30M24.00M22.90M21.50M20.90M22.10M20.50M
Other Growth
19.07%16.27%8.60%11.71%27.22%74.17%166.27%150.00%
Period EndingJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
United States
3.01B3.03B3.04B2.99B2.93B2.85B2.74B2.62B
United States Growth
2.49%6.45%10.85%14.12%17.90%19.96%24.41%25.96%
International
149.10M138.20M145.70M138.50M145.40M146.30M137.70M136.30M
International Growth
2.54%-5.54%5.81%1.61%12.28%17.70%9.90%9.65%